SpringWorks Therapeutics Inc
SWTX·Stocks·Biotechnology·United States·Nasdaq·USD
Price
$47.00
Today
+0.0%
YTD
+0.2%
About
SpringWorks Therapeutics Inc is a clinical-stage biopharmaceutics enterprise that acquires, develops, and markets medicines for patients within the United States. These therapies target rare diseases and cancers with unmet medical need. The company is headquartered in Stamford, Connecticut, and was established in 2017. The SWTX ticker identifies SpringWorks on the NASDAQ GS. Remain updated on SWTX share price developments by adding this item to your watchlist.
Price chart
Closing price history for SWTX (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-13.78
P/S (TTM)16.02
P/B (TTM)8.44
Market cap$3.54B
Cap tierMid-cap
Industry avg P/E-2.16
Profitability
Gross margin91.48%
EBIT margin-120.52%
Net margin-169.47%
ROE-51.57%
ROA-43.70%
Earnings & Revenue
Revenue (TTM)$219.67M
Revenue growth (1Y)+730.4%
EPS (TTM)-$3.41
Free cash flow$-169.33M
Total debt$7.39M
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.15
Employees368
Next earnings7 Aug '25
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.